Therapeutic effects of tangshen formula on diabetic nephropathy in rats

PLoS ONE

Volumn 11, Issue 1, 2016, Pages

  Zhao, Tingting ^a   Sun, Sifan ^a   Zhang, Haojun ^a   Huang, Xiaoru ^b   Yan, Meihua ^a   Dong, Xi ^a   Wen, Yumin ^a   Wang, Hua ^a   Lan, Hui Yao ^b   Li, Ping ^a  

^a CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CCL2 PROTEIN, RAT; CYTOKINE; HERBACEOUS AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR;

ANIMAL; CHINESE MEDICINE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DRUG EFFECTS; KIDNEY; MALE; METABOLISM; PATHOLOGY; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CHEMOKINE CCL2; CYTOKINES; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DRUGS, CHINESE HERBAL; INTERLEUKIN-1BETA; KIDNEY; MALE; MEDICINE, CHINESE TRADITIONAL; NF-KAPPA B; RATS; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84958213342     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0147693     Document Type: Article

References (33)

1. Schena FP, Gesualdo L. Pathogenetic mechanisms of diabetic nephropathy. J Am Soc Nephrol. 2005; 16 Suppl 1:S30-33.
2. Mason RM, Wahab NA. Extracellular matrix metabolism in diabetic nephropathy. J Am Soc Nephrol. 2003; 14:1358-1373.
3. Duran-Salgado MB, Rubio-Guerra AF. Diabetic nephropathy and inflammation. World J Diabetes. 2014; 5:393-398. doi: 10.4239/wjd.v5.i3.393
4. Lim AK, Tesch GH. Inflammation in diabetic nephropathy. Mediators Inflamm. 2012; 2012:146154. doi: 10.1155/2012/146154
5. Nguyen D, Ping F, Mu W, Hill P, Atkins RC, Chadban SJ.Macrophage accumulation in human progressive diabetic nephropathy. Nephrology (Carlton). 2006; 11:226-231.
6. Lan HY. Diverse roles of TGF-β/Smads in renal fibrosis and inflammation. International journal of biological sciences. 2011; 7:1056.
7. Sato M, Muragaki Y, Saika S, Roberts AB, Ooshima A. Targeted disruption of TGF-β1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. Journal of Clinical Investigation. 2003; 112:1486.
8. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature. 2003; 425:577-584.
9. Lan HY, Chung AC. Transforming growth factor-beta and Smads. Contrib Nephrol. 2011; 170:75-82. doi: 10.1159/000324949
10. El Mesallamy HO, Ahmed HH, Bassyouni AA, Ahmed AS. Clinical significance of inflammatory and fibrogenic cytokines in diabetic nephropathy. Clinical biochemistry. 2012; 45:646-650. doi: 10.1016/j.clinbiochem.2012.02.021
11. Kavsak P, Rasmussen RK, Causing CG, Bonni S, Zhu H, Thomsen GH, et al. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. Mol Cell 2000; 6:1365-1375.
12. Chen HY, Huang XR, Wang W, Li JH, Heuchel RL, Chung AC, et al. The protective role of Smad7 in diabetic kidney disease: mechanism and therapeutic potential. Diabetes. 2011; 60:590-601. doi: 10.2337/db10-0403
13. Chung AC, Huang XR, Zhou L, Heuchel R, Lai KN, Lan HY. Disruption of the Smad7 gene promotes renal fibrosis and inflammation in unilateral ureteral obstruction (UUO) in mice. Nephrol Dial Transplant. 2009; 24:1443-1454. doi: 10.1093/ndt/gfn699
14. Zhao TT, Zhang HJ, Lu XG, Huang XR, Zhang WK, Wang H, et al. Chaihuang-Yishen granule inhibits diabetic kidney disease in rats through blocking TGF-beta/Smad3 signaling. PLoS One. 2014; 9: e90807. doi: 10.1371/journal.pone.0090807
15. Wen X, Zeng Y, Liu L, Zhang H, Xu W, Li N, et al. Zhenqing recipe alleviates diabetic nephropathy in experimental type 2 diabetic rats through suppression of SREBP-1c. J Ethnopharmacol. 2012; 142:144-150. doi: 10.1016/j.jep.2012.04.028
16. Zhang H, Li P, Burczynski FJ, Gong Y, Choy P, Sha H, Li J: Attenuation of Diabetic Nephropathy in Otsuka Long-Evans Tokushima Fatty (OLETF) Rats with a Combination of Chinese Herbs (Tangshen Formula). Evid Based Complement Alternat Med. 2011; 2011:613737. doi: 10.1155/2011/613737
17. Li P, Chen Y, Liu J, Hong J, Deng Y, Yang F, et al. Efficacy and safety of tangshen formula on patients with type 2 diabetic kidney disease: A multicenter double-blinded randomized placebo-controlled trial. PLoS One. 2015; 10:e0126027. doi: 10.1371/journal.pone.0126027
18. Committee NP. In: Pharmacopoeia of The People's Republic of China. Beijing: China Medical Pharmaceutical Science & Technology Publishing House; 2010.
19. Zhu B, Gong Y, Chen P, Zhang H, Zhao T, Li P. Increased DNase I activity in diabetes might be associated with injury of pancreas. Mol Cell Biochem. 2014; 393:23-32. doi: 10.1007/s11010-014-2043-1
20. Butler AE, Janson J, Soeller WC, Butler PC; Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid. Diabetes. 2003; 52:2304-2314.
21. Lan HY, Mu W, Nikolic-Paterson DJ, Atkins RC. A novel, simple, reliable, and sensitive method for multiple immunoenzyme staining: use of microwave oven heating to block antibody crossreactivity and retrieve antigens. J Histochem Cytochem. 1995; 43:97-102.
22. Meng XM, Huang XR, Xiao J, Chen HY, Zhong X, Chung AC, et al. Diverse roles of TGF-beta receptor II in renal fibrosis and inflammation in vivo and in vitro. J Pathol. 2012; 227:175-188. doi: 10.1002/path.3976
23. Liu GX, Li YQ, Huang XR, Wei L, Chen HY, Shi YJ, et al. Disruption of Smad7 promotes ANG II-mediated renal inflammation and fibrosis via Sp1-TGF-beta/Smad3-NF.kappaB-dependent mechanisms in mice. PLoS One. 2013; 8:e53573. doi: 10.1371/journal.pone.0053573
24. Huang W, Xu L, Zhou X, Gao C, Yang M, Chen G, et al. High glucose induces activation of NF-kappaB inflammatory signaling through IkappaBalpha sumoylation in rat mesangial cells. Biochem Biophys Res Commun. 2013; 438:568-574. doi: 10.1016/j.bbrc.2013.07.065
25. Hong SW, Isono M, Chen S, Iglesias-De La Cruz MC, Han DC, Ziyadeh FN: Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse. Am J Pathol. 2001; 158:1653-1663.
26. Li JH, Huang XR, Zhu HJ, Oldfield M, Cooper M, Truong LD, et al.Advanced glycation end products activate Smad signaling via TGF-beta-dependent and independent mechanisms: implications for diabetic renal and vascular disease. FASEB J. 2004; 18:176-178.
27. Williams MD, Nadler JL. Inflammatory mechanisms of diabetic complications. Curr Diab Rep. 2007; 7:242-248.
28. Pickart CM. Mechanisms underlying ubiquitination Annu Rev Biochem. 2001; 70:503-533.
29. Glasgow E, Mishra L. Transforming growth factor-beta signaling and ubiquitinators in cancer. Endocr Relat Cancer. 2008; 15:59-72. doi: 10.1677/ERC-07-0168
30. Fukasawa H, Yamamoto T, Togawa A, Ohashi N, Fujigaki Y, Oda T, et al. Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice. Proc Natl Acad Sci U S A. 2004; 101(23):8687-8692.
31. Liu Z, Huang XR, Chen HY, Penninger JM, Lan HY. Loss of angiotensin-converting enzyme 2 enhances TGF-b/Smad-mediated renal fibrosis and NF-kB-driven renal inflammation in a mouse model of obstructive nephropathy. Laboratory Investigation. 2012; 92:650-661. doi: 10.1038/labinvest.2012. 2
32. Ng YY, Hou CC, Wang W, Huang XR, Lan HY. Blockade of NFkappaB activation and renal inflammation by ultrasound-mediated gene transfer of Smad7 in rat remnant kidney. Kidney Int Suppl. 2005; S83-91.
33. Wang W, Huang XR, Li AG, Liu F, Li JH, Truong LD, et al. Signaling mechanism of TGF-beta1 in prevention of renal inflammation: role of Smad7. J Am Soc Nephrol. 2005; 16:1371-1383.